Iain Charles Wilcock

Oxxon Therapeutics, Inc. develops and manufactures antigen-specific immunotherapies to treat patients with chronic infectious diseases and cancer. The company has three development programs in hepatitis, melanoma, and HIV. Oxxon Therapeutics was founded in 1999 by Dr. Joerg Schneider and is located at Oxford, UK.

Kebony AS operates as a holding company which engages in the research, development, and production of wooden products. The firm’s products include cladding, decking, construction, roof and rough sawn. The company was founded in 1997 and is headquartered in Oslo, Norway.

Seventure Partners SA (Seventure) is a Venture Capital firm, a subsidiary of Natixis SA founded in 1997. Seventure Partners SA is headquartered in Paris.

Microbiotica Ltd. performs research and experimental development on biotechnology. The company was founded by Michael Anthony Romanos, Trevor David Lawley and Gordon Dougan in December 2016 and is headquartered in Cambridge, the United Kingdom.

Brathew Ltd. develops building projects.

Nesta Investment Management LLP. (NESTA Investments) subsidiary of Nesta formerly NESTA, is a venture capital firm founded in 1998. The firm is headquartered in London city United Kingdom.

Avidex Ltd. develops and discovers drugs for the treatment of cancer and autoimmune diseases. The company develops small molecule and protein therapeutics involving T cell receptors. Avidex was founded in 1999 and is headquartered in Abingdon, UK

SPARK Venture Management Ltd. (SPARK Ventures) is a venture capital subsidiary of Querist Ltd. founded in 1989 by Kiko Duffy and Thomas Alfred Teichman. The firm is headquartered in London, United Kingdom.

Vivostat A/S provides cardiac, thoracic and orthopaedic surgery medical devices. It offers vivostat system, an automated system for the on-site preparation and application of patient-derived fibrin sealant or platelet rich fibrin. Its products include Vivostat autologous fibrin sealant for various settings in surgical areas, transfusion centers, or blood banks and Vivostat platelet rich fibrin, which utilizes the patient's own blood to derive either a surgical sealant to prevent and stop bleedings, or a gel with a high concentration of growth factors that stimulates the healing of chronic wounds, as well as provides application devices. The compnay was founded in 2001 by Tom Bjerg Lauritzen and Niels Hvid and is headquartered in Alleroed, Denmark.